BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38440354)

  • 1. STEAP3 Affects Ovarian Cancer Progression by Regulating Ferroptosis through the p53/SLC7A11 Pathway.
    Han Y; Fu L; Kong Y; Jiang C; Huang L; Zhang H
    Mediators Inflamm; 2024; 2024():4048527. PubMed ID: 38440354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer.
    Zhang X; Zheng X; Ying X; Xie W; Yin Y; Wang X
    J Transl Med; 2023 May; 21(1):334. PubMed ID: 37210575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSDL2 knockdown promotes the progression of cholangiocarcinoma by inhibiting ferroptosis through the P53/SLC7A11 axis.
    Ma S; Ma Y; Qi F; Lei J; Chen F; Sun W; Wang D; Zhou S; Liu Z; Lu Z; Zhang D
    World J Surg Oncol; 2023 Sep; 21(1):293. PubMed ID: 37718459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of STEAP3-based molecular subtype and risk model in ovarian cancer.
    Zhao Z; Sun C; Hou J; Yu P; Wei Y; Bai R; Yang P
    J Ovarian Res; 2023 Jun; 16(1):126. PubMed ID: 37386521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STEAP3 Affects Ferroptosis and Progression of Renal Cell Carcinoma Through the p53/xCT Pathway.
    Ye CL; Du Y; Yu X; Chen ZY; Wang L; Zheng YF; Liu XH
    Technol Cancer Res Treat; 2022; 21():15330338221078728. PubMed ID: 35275508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. circRNA circSnx12 confers Cisplatin chemoresistance to ovarian cancer by inhibiting ferroptosis through a miR-194-5p/SLC7A11 axis.
    Qin K; Zhang F; Wang H; Wang N; Qiu H; Jia X; Gong S; Zhang Z
    BMB Rep; 2023 Mar; 56(2):184-189. PubMed ID: 36617466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 Activates the Lipoxygenase Activity of ALOX15B via Inhibiting SLC7A11 to Induce Ferroptosis in Bladder Cancer Cells.
    Li X; Xiong W; Wang Y; Li Y; Cheng X; Liu W
    Lab Invest; 2023 May; 103(5):100058. PubMed ID: 36801644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of STEAP3 in lung squamous cell carcinoma: Regulating EGFR to affect cell proliferation and ferroptosis.
    Shi H; Lei S; Xiong L; Du S; Shi Y
    Arch Biochem Biophys; 2024 Jan; 751():109842. PubMed ID: 38040224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol protected against the development of endometriosis by promoting ferroptosis through miR-21-3p/p53/SLC7A11 signaling pathway.
    Zou W; Wang X; Xia X; Zhang T; Nie M; Xiong J; Fang X
    Biochem Biophys Res Commun; 2024 Jan; 692():149338. PubMed ID: 38043156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer.
    Zhou X; Zou L; Chen W; Yang T; Luo J; Wu K; Shu F; Tan X; Yang Y; Cen S; Li C; Mao X
    Pharmacol Res; 2021 Feb; 164():105305. PubMed ID: 33197601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HRD1 functions as a tumor suppressor in ovarian cancer by facilitating ubiquitination-dependent SLC7A11 degradation.
    Wang Y; Wang S; Zhang W
    Cell Cycle; 2023 May; 22(9):1116-1126. PubMed ID: 36809917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
    Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
    Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM4A-mediated histone demethylation of SLC7A11 inhibits cell ferroptosis in osteosarcoma.
    Chen M; Jiang Y; Sun Y
    Biochem Biophys Res Commun; 2021 Apr; 550():77-83. PubMed ID: 33689883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA binding protein DAZAP1 promotes HCC progression and regulates ferroptosis by interacting with SLC7A11 mRNA.
    Wang Q; Guo Y; Wang W; Liu B; Yang G; Xu Z; Li J; Liu Z
    Exp Cell Res; 2021 Feb; 399(1):112453. PubMed ID: 33358859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA ADAMTS9-AS1 attenuates ferroptosis by Targeting microRNA-587/solute carrier family 7 member 11 axis in epithelial ovarian cancer.
    Cai L; Hu X; Ye L; Bai P; Jie Y; Shu K
    Bioengineered; 2022 Apr; 13(4):8226-8239. PubMed ID: 35311457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer.
    Hong T; Lei G; Chen X; Li H; Zhang X; Wu N; Zhao Y; Zhang Y; Wang J
    Redox Biol; 2021 Jun; 42():101928. PubMed ID: 33722571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Noncoding RNA LINC00578 Inhibits Ferroptosis in Pancreatic Cancer via Regulating SLC7A11 Ubiquitination.
    Li H; Wei Y; Wang J; Yao J; Zhang C; Yu C; Tang Y; Zhu D; Yang J; Zhou J
    Oxid Med Cell Longev; 2023; 2023():1744102. PubMed ID: 36846713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion.
    Han M; Xu R; Wang S; Yang N; Ni S; Zhang Q; Xu Y; Zhang X; Zhang C; Wei Y; Ji J; Huang B; Zhang D; Chen A; Li W; Bjerkvig R; Li X; Wang J
    Neoplasia; 2018 Jun; 20(6):543-554. PubMed ID: 29730475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone induces ferroptosis via P53/SLC7A11/GPX4 pathway in glucocorticoid-induced osteonecrosis of the femoral head.
    Sun F; Zhou JL; Liu ZL; Jiang ZW; Peng H
    Biochem Biophys Res Commun; 2022 Apr; 602():149-155. PubMed ID: 35276555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.
    Yang J; Zhou Y; Xie S; Wang J; Li Z; Chen L; Mao M; Chen C; Huang A; Chen Y; Zhang X; Khan NUH; Wang L; Zhou J
    J Exp Clin Cancer Res; 2021 Jun; 40(1):206. PubMed ID: 34162423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.